Sign in or register to see full information and data.

Studies / CAVD 528


Study information

Grant Affiliation:Haynes: B cell Lineage Envelope Design from RV144 Antibodies
Strategy:Prophylactic neutralizing Ab
Study Type:Antibody Screening
Species:Non-Organism Study
Stage:Assays Completed
Study Start Date:2015-10-20
Study Made Public:2017-09-28


Assaying neutralization breadth and potency of recombinantly expressed antibodies isolated from RV305 leukapheresis samples


CAVD 528 is a monoclonal antibody screening study evaluating broadly neutralizing antibodies in select RV305 participants.


ALVAC (vCP1521) AIDSVAX B/E Saline (non-specific) Placebo ALVAC Placebo AIDSVAX B/E

Integrated data

No integrated data is available for this study.

Non-integrated data

No non-integrated data is available for this study.